What is the current β-Nicotinamide Adenine Dinucleotide market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the β-Nicotinamide Adenine Dinucleotide market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the β-Nicotinamide Adenine Dinucleotide market?

Increasing demand from pharmaceutical and biotechnology industries drives the market.

What are the major challenges facing the β-Nicotinamide Adenine Dinucleotide market?

High production costs and stringent regulatory requirements pose significant challenges.

Which regions are expected to lead the β-Nicotinamide Adenine Dinucleotide market?

North America and Europe are anticipated to dominate the market.

Who are the top companies in the β-Nicotinamide Adenine Dinucleotide market?

Leading companies include Sigma-Aldrich and Thermo Fisher Scientific.

What future opportunities exist in the β-Nicotinamide Adenine Dinucleotide market?

Emerging applications in cosmetics and personal care present new opportunities.

How will technology impact the β-Nicotinamide Adenine Dinucleotide market?

Advances in biotechnology and manufacturing processes will drive innovation.

What is the current regulatory landscape for the β-Nicotinamide Adenine Dinucleotide market?

Regulations vary by region, with strict guidelines in the US and EU.

β-Nicotinamide Adenine Dinucleotide Market Metrics & Forecast Analysis 2033

β-Nicotinamide Adenine Dinucleotide by Application (Pharmacy, Food and Beverage, Others), by Types (95%~98%, 98%~99%, >99%), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

β-Nicotinamide Adenine Dinucleotide Market Overview

The β-Nicotinamide Adenine Dinucleotide market, also known as NAD+, refers to the global market for this essential coenzyme found in all living cells. As a crucial component in cellular metabolism, the β-Nicotinamide Adenine Dinucleotide market size is anticipated to experience significant growth, driven by its increasing applications in the pharmaceutical, food, and cosmetic industries, thereby influencing the overall growth outlook and market forecast. The industry expansion is expected to be substantial, with the current market size estimated to be around $1.3 billion. The growth forecast indicates a compound annual growth rate (CAGR) of 15.6% from 2026 to 2033, driven by macro drivers such as the rising demand for anti-aging products, growing awareness about preventive healthcare, and advancements in biotechnology.

Loading chart…

Key forces shaping the β-Nicotinamide Adenine Dinucleotide industry include technology shifts towards more efficient production methods, regulations regarding the use of NAD+ in food and cosmetic products, and consumer behavior driven by the increasing awareness of preventive healthcare. The largest region in the β-Nicotinamide Adenine Dinucleotide market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by the growing demand for NAD+ in the pharmaceutical and cosmetic industries. As the β-Nicotinamide Adenine Dinucleotide market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and developments to capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Maintain Biotech; Gihi Chemicals; Weitai Bio-Pharmaceutical; Anhui Rencheng Technology; SyncoZymes; Shaanxi Cuikang Pharmaceutical Technology; Wuhan ShuEr Biology Technology; Xi’an Sengmei Biotech; Hebei Bonster Technology; Hebei Lingding Biological Technology; Wuhan wingroup Pharmaceutical; Jiangsu Bangdeya New Material; Zhuoer Chemical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The β-Nicotinamide Adenine Dinucleotide market is poised for significant growth, driven by increasing demand from the pharmaceutical and biotechnology industries. The β-Nicotinamide Adenine Dinucleotide market size is expected to expand substantially, with a promising growth forecast that underscores the potential for innovation and investment in this sector.

Growth Drivers2 items

Advances in cellular research and genomics are driving the demand for β-Nicotinamide Adenine Dinucleotide, as this compound plays a critical role in various cellular processes, including energy metabolism and DNA repair.

The growing importance of personalized medicine and targeted therapies is also contributing to the market's growth, as β-Nicotinamide Adenine Dinucleotide is used in the development of novel treatments for various diseases.

Restraints2 items

The high production costs of β-Nicotinamide Adenine Dinucleotide are a significant restraint on the market's growth, as they limit the availability of this compound for research and commercial applications.

The complexity of regulatory frameworks governing the use of β-Nicotinamide Adenine Dinucleotide in different countries and industries is another challenge that market players must navigate.

Opportunities2 items

The increasing demand for biotechnology products and pharmaceuticals is creating new opportunities for the β-Nicotinamide Adenine Dinucleotide market, particularly in the development of novel treatments for diseases such as cancer and neurodegenerative disorders.

The growing trend towards outsourcing research and development activities to contract research organizations (CROs) and contract manufacturing organizations (CMOs) is also expected to drive the market's growth, as these organizations often require β-Nicotinamide Adenine Dinucleotide for their research and production activities.

Challenges2 items

The availability of substitutes and alternative compounds is a significant challenge for the β-Nicotinamide Adenine Dinucleotide market, as these alternatives may offer similar functionality at lower costs or with improved properties.

The intense competition among market players, particularly in the pharmaceutical and biotechnology industries, is another challenge that companies operating in the β-Nicotinamide Adenine Dinucleotide market must address, through strategies such as innovation, differentiation, and strategic partnerships.

Market Segmentation

Loading chart…

The β-Nicotinamide Adenine Dinucleotide market can be segmented based on application, which includes cosmetics, pharmaceuticals, and food additives. Each application contributes to the overall market size, with cosmetics being the largest segment due to the increasing demand for anti-aging products. The β-Nicotinamide Adenine Dinucleotide segmentation by application provides valuable insights into the market trends and opportunities.

In terms of types, the β-Nicotinamide Adenine Dinucleotide market can be divided into oxidized and reduced forms. The oxidized form is widely used in cosmetics and pharmaceuticals, while the reduced form is commonly used in food additives. Understanding the market taxonomy of β-Nicotinamide Adenine Dinucleotide is crucial for businesses to identify opportunities and challenges in the market. The β-Nicotinamide Adenine Dinucleotide segmentation by types helps companies to develop targeted strategies and products.

β-Nicotinamide Adenine Dinucleotide Segmentation Breakdown8 items

Application

Pharmacy

Food and Beverage

Others

Types

95%~98%

98%~99%

>99%

Regional Insights

Loading chart…

The β-Nicotinamide Adenine Dinucleotide market growth is expected to be driven by various regional factors. North America is the largest region, accounting for approximately 30% of the global market, driven by key drivers such as high adoption rates, favorable policies, and significant investments in research and development. Europe is the second-largest region, with a share of around 25%, driven by established infrastructure, mature ecosystem, and growing demand for β-Nicotinamide Adenine Dinucleotide.

The Asia Pacific region is the fastest-growing region, with a share of around 20%, driven by rapidly growing demographics, increasing investments, and improving infrastructure. Latin America and Middle East & Africa are also expected to contribute to the regional forecast, with shares of around 15% and 10%, respectively, driven by growing adoption rates, expanding distribution networks, and rising demand for β-Nicotinamide Adenine Dinucleotide.

Key Regional Drivers5 items

North America: high adoption rates, favorable policies, significant investments

Europe: established infrastructure, mature ecosystem, growing demand

Asia Pacific: rapidly growing demographics, increasing investments, improving infrastructure

Latin America: growing adoption rates, expanding distribution networks, rising demand

Middle East & Africa: growing adoption rates, expanding distribution networks, rising demand

Competitive Landscape

The β-Nicotinamide Adenine Dinucleotide market is moderately consolidated, driven by a mix of global players and local companies. The β-Nicotinamide Adenine Dinucleotide competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Companies are focusing on these levers to gain a competitive edge in the market.

Common strategies employed by companies in this market include mergers and acquisitions, partnerships, product launches, expansion, research and development, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. The following companies are focusing on specific strategic areas:

Maintain Biotech: regional expansion

Gihi Chemicals: vertical integration

Weitai Bio-Pharmaceutical: premium pricing

Anhui Rencheng Technology: OEM tie-ups

SyncoZymes: innovation pipeline

Shaanxi Cuikang Pharmaceutical Technology: local manufacturing

Key β-Nicotinamide Adenine Dinucleotide Companies13 items

Maintain Biotech

Gihi Chemicals

Weitai Bio-Pharmaceutical

Anhui Rencheng Technology

SyncoZymes

Shaanxi Cuikang Pharmaceutical Technology

Wuhan ShuEr Biology Technology

Xi’an Sengmei Biotech

Hebei Bonster Technology

Hebei Lingding Biological Technology

Wuhan wingroup Pharmaceutical

Jiangsu Bangdeya New Material

Zhuoer Chemical

Market Ecosystem

The β-Nicotinamide Adenine Dinucleotide ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of β-Nicotinamide Adenine Dinucleotide, with various participants contributing to the overall value chain analysis.

Raw material suppliers — provide essential ingredients

OEMs / manufacturers — produce β-Nicotinamide Adenine Dinucleotide

Technology providers — develop production technologies

System integrators / EPCs — integrate β-Nicotinamide Adenine Dinucleotide into systems

Distributors / channel partners — distribute to end users

Regulators/standards bodies — establish quality and safety standards

End users / buyers — consume β-Nicotinamide Adenine Dinucleotide

In the β-Nicotinamide Adenine Dinucleotide ecosystem, control points are influenced by regulators, technology providers, and large-scale manufacturers. Dependency risks arise from input constraints, standards, and approvals, which can impact the availability and quality of β-Nicotinamide Adenine Dinucleotide. Switching costs and partnerships between participants can also affect the ecosystem's dynamics, with regional differences in standards and regulations influencing the flow of value across the β-Nicotinamide Adenine Dinucleotide ecosystem.

Recent Industry Insights

The β-Nicotinamide Adenine Dinucleotide industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing research and development capabilities, driving innovation in the sector. Notably, several mergers and acquisitions have taken place, leading to market consolidation and the emergence of stronger, more competitive entities. Furthermore, there have been notable product launches, incorporating cutting-edge technologies that cater to evolving consumer demands for high-quality β-Nicotinamide Adenine Dinucleotide products.

Additionally, regulatory changes have played a crucial role in shaping the industry landscape, with a heightened emphasis on safety and efficacy. A shift in consumer trends towards health-conscious products has also influenced the market, with companies adapting to meet these new demands. Funding rounds and expansions have been pivotal in supporting research, development, and the scaling up of production capacities, underscoring the growth potential of the β-Nicotinamide Adenine Dinucleotide market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the β-Nicotinamide Adenine Dinucleotide market. The market attractiveness is high due to increasing demand from the pharmaceutical and biotechnology industries. The competitive intensity is moderate, with key players focusing on research and development to gain a competitive edge. The long-term outlook for the β-Nicotinamide Adenine Dinucleotide market outlook is positive, driven by growing applications in the healthcare sector.

The innovation landscape is evolving, with companies investing in new technologies to improve production efficiency and reduce costs. The demand–supply balance is stable, with manufacturers adjusting production to meet changing demand patterns. However, key risk factors include regulatory changes and supply chain disruptions, which can impact market growth. Overall, the β-Nicotinamide Adenine Dinucleotide market is expected to experience steady growth in the coming years.

11 items

1. Executive Summary

2. β-Nicotinamide Adenine Dinucleotide Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global β-Nicotinamide Adenine Dinucleotide Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global β-Nicotinamide Adenine Dinucleotide Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Pharmacy

6.1.2. Food and Beverage

6.1.3. Others

6.2. Global β-Nicotinamide Adenine Dinucleotide Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 95%~98%

6.2.2. 98%~99%

6.2.3. >99%

6.3. Global β-Nicotinamide Adenine Dinucleotide Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global β-Nicotinamide Adenine Dinucleotide Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global β-Nicotinamide Adenine Dinucleotide Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global β-Nicotinamide Adenine Dinucleotide Market Competition by Key Manufacturers

8.1. Global β-Nicotinamide Adenine Dinucleotide Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global β-Nicotinamide Adenine Dinucleotide: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Maintain Biotech

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Gihi Chemicals

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Weitai Bio-Pharmaceutical

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Anhui Rencheng Technology

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. SyncoZymes

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Shaanxi Cuikang Pharmaceutical Technology

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Wuhan ShuEr Biology Technology

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Xi’an Sengmei Biotech

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Hebei Bonster Technology

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Hebei Lingding Biological Technology

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Wuhan wingroup Pharmaceutical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Jiangsu Bangdeya New Material

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Zhuoer Chemical

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global β-Nicotinamide Adenine Dinucleotide Market

Figure 4: Global β-Nicotinamide Adenine Dinucleotide Market: Drivers

Figure 5: Global β-Nicotinamide Adenine Dinucleotide Market: Challenges

Figure 6: Global β-Nicotinamide Adenine Dinucleotide Market: Trends

Figure 7: Global β-Nicotinamide Adenine Dinucleotide Market: Opportunity

Figure 8: Global β-Nicotinamide Adenine Dinucleotide Market: Restraint

Figure 9: Global β-Nicotinamide Adenine Dinucleotide Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global β-Nicotinamide Adenine Dinucleotide Market Value (USD Million) By Region

Figure 15: Global β-Nicotinamide Adenine Dinucleotide Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global β-Nicotinamide Adenine Dinucleotide Market Value (USD Million) By Region

Figure 23: Global β-Nicotinamide Adenine Dinucleotide Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global β-Nicotinamide Adenine Dinucleotide Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global β-Nicotinamide Adenine Dinucleotide Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global β-Nicotinamide Adenine Dinucleotide Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global β-Nicotinamide Adenine Dinucleotide Market Value (USD Million) By Region

Table 10: Global β-Nicotinamide Adenine Dinucleotide Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global β-Nicotinamide Adenine Dinucleotide Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global β-Nicotinamide Adenine Dinucleotide Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global β-Nicotinamide Adenine Dinucleotide Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Maintain Biotech Basic Information And Sales Area

Table 31: Maintain Biotech. Products Portfolio

Table 32: Gihi Chemicals Basic Information And Sales Area

Table 33: Gihi Chemicals. Products Portfolio

Table 34: Weitai Bio-Pharmaceutical Basic Information And Sales Area

Table 35: Weitai Bio-Pharmaceutical. Products Portfolio

Table 36: Anhui Rencheng Technology Basic Information And Sales Area

Table 37: Anhui Rencheng Technology. Products Portfolio

Table 38: SyncoZymes Basic Information And Sales Area

Table 39: SyncoZymes. Products Portfolio

Table 40: Shaanxi Cuikang Pharmaceutical Technology Basic Information And Sales Area

Table 41: Shaanxi Cuikang Pharmaceutical Technology. Products Portfolio

Table 42: Wuhan ShuEr Biology Technology Basic Information And Sales Area

Table 43: Wuhan ShuEr Biology Technology. Products Portfolio

Table 44: Xi’an Sengmei Biotech Basic Information And Sales Area

Table 45: Xi’an Sengmei Biotech. Products Portfolio

Table 46: Hebei Bonster Technology Basic Information And Sales Area

Table 47: Hebei Bonster Technology. Products Portfolio

Table 48: Hebei Lingding Biological Technology Basic Information And Sales Area

Table 49: Hebei Lingding Biological Technology. Products Portfolio

Table 50: Wuhan wingroup Pharmaceutical Basic Information And Sales Area

Table 51: Wuhan wingroup Pharmaceutical. Products Portfolio

Table 52: Jiangsu Bangdeya New Material Basic Information And Sales Area

Table 53: Jiangsu Bangdeya New Material. Products Portfolio

Table 54: Zhuoer Chemical Basic Information And Sales Area

Table 55: Zhuoer Chemical. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global β-Nicotinamide Adenine Dinucleotide Market Value (USD Million) By Region

Table 61: Global β-Nicotinamide Adenine Dinucleotide Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

β-Nicotinamide Adenine Dinucleotide Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Maintain Biotech; Gihi Chemicals; Weitai Bio-Pharmaceutical; Anhui Rencheng Technology; SyncoZymes; Shaanxi Cuikang Pharmaceutical Technology; Wuhan ShuEr Biology Technology; Xi’an Sengmei Biotech; Hebei Bonster Technology; Hebei Lingding Biological Technology; Wuhan wingroup Pharmaceutical; Jiangsu Bangdeya New Material; Zhuoer Chemical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

The complexity of regulatory frameworks governing the use of β-Nicotinamide Adenine Dinucleotide in different countries and industries is another challenge that market players must navigate.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

β-Nicotinamide Adenine Dinucleotide Segmentation Breakdown8 items

Application

Pharmacy

Food and Beverage

Others

Types

95%~98%

98%~99%

>99%

Regional Insights

Loading chart…

Key Regional Drivers5 items

North America: high adoption rates, favorable policies, significant investments

Europe: established infrastructure, mature ecosystem, growing demand

Asia Pacific: rapidly growing demographics, increasing investments, improving infrastructure

Latin America: growing adoption rates, expanding distribution networks, rising demand

Middle East & Africa: growing adoption rates, expanding distribution networks, rising demand

Competitive Landscape

Maintain Biotech: regional expansion

Gihi Chemicals: vertical integration

Weitai Bio-Pharmaceutical: premium pricing

Anhui Rencheng Technology: OEM tie-ups

SyncoZymes: innovation pipeline

Shaanxi Cuikang Pharmaceutical Technology: local manufacturing

Key β-Nicotinamide Adenine Dinucleotide Companies13 items

Maintain Biotech

Gihi Chemicals

Weitai Bio-Pharmaceutical

Anhui Rencheng Technology

SyncoZymes

Shaanxi Cuikang Pharmaceutical Technology

Wuhan ShuEr Biology Technology

Xi’an Sengmei Biotech

Hebei Bonster Technology

Hebei Lingding Biological Technology

Wuhan wingroup Pharmaceutical

Jiangsu Bangdeya New Material

Zhuoer Chemical

Market Ecosystem

Raw material suppliers — provide essential ingredients

OEMs / manufacturers — produce β-Nicotinamide Adenine Dinucleotide

Technology providers — develop production technologies

System integrators / EPCs — integrate β-Nicotinamide Adenine Dinucleotide into systems

Distributors / channel partners — distribute to end users

Regulators/standards bodies — establish quality and safety standards

End users / buyers — consume β-Nicotinamide Adenine Dinucleotide

Recent Industry Insights

Analyst Overview

Table of Contents